Page last updated: 2024-10-25

cilostazol and Familial Primary Pulmonary Hypertension

cilostazol has been researched along with Familial Primary Pulmonary Hypertension in 1 studies

Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.

Research Excerpts

ExcerptRelevanceReference
"Cilostazol is a PDE3 inhibitor and used to treat peripheral arterial disease."1.39The effect of cilostazol on right heart function and pulmonary pressure. ( Akgun, T; Alici, G; Alizade, E; Demir, S; Emiroglu, Y; Ozkan, B; Pala, S; Sahin, M; Turkmen, MM; Yazicioglu, MV, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sahin, M1
Alizade, E1
Pala, S1
Alici, G1
Ozkan, B1
Akgun, T1
Emiroglu, Y1
Demir, S1
Yazicioglu, MV1
Turkmen, MM1

Other Studies

1 other study available for cilostazol and Familial Primary Pulmonary Hypertension

ArticleYear
The effect of cilostazol on right heart function and pulmonary pressure.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:6

    Topics: Aged; Cilostazol; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary;

2013